Clinical Trial Update: Aprepitant and Granisetron for the Prophylaxis of Radiation Induced Nausea and Vomiting - A Pilot Study [Phase 2]

View source ↗

Summary

A Phase 2 pilot study evaluated aprepitant and granisetron for prophylaxis of radiation-induced nausea and vomiting; the trial has been terminated with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nausea
• Vomiting

Drugs mentioned

• Aprepitant (aprepitant)
• Granisetron (granisetron)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Nausea, Vomiting | Phase 2 | Status: TERMINATED | Results posted: 2014-01-20